Amigo AI

About Amigo AI

Amigo is a trusted platform for building, training, and deploying clinical AI agents, designed to enhance healthcare delivery by making care teams feel 10x bigger while maintaining safety and reliability standards. Their mission is to transform healthcare practices through AI tailored to unique patient needs and workflows.

Products & Services

Clinical AI Agents Platform:A platform to define, train, deploy, and optimize custom clinical agents for healthcare workflows, featuring rigorous validation, safety scalability, and integration with major EHRs and clinical systems.

Amigo Digital Residency:A training program for clinical agents using millions of simulated patient interactions with virtual patients and supervised evaluations to ensure reliability.

Specialties

Primary Care Digital Health Orthopedic Care Women's Health Behavioral Health Cancer Care AI for Clinical Workflows HIPAA, SOC 2, GDPR Compliance

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 11000000 MR: - FA: $11M FAN: 11000000	D: 2026-03-10 FD: 2026-03-10	2 investors

Series A Latest

2026-03-10

$11.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jay Shah

Cancer Surgeon & Chief of Medical Staff

P

Patrick DiLoreto

Head of Product

S

Sidd Arora

Founder, The Care Clinic

Recent News

Amigo AI Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised